Matches in Nanopublications for { ?s ?p "[To our knowledge this is the first study to demonstrate the epidemiologic association between HLA-A*02 and the risk of CML, and we discuss this in the context of recent immunological studies reporting data on BCR-ABL fusion peptide presentation and subsequent immune response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP476650.RAB-nzCY73edFxBNgb6CdLjUYFzvy7ZfFZzbJZNpy-NFw130_assertion description "[To our knowledge this is the first study to demonstrate the epidemiologic association between HLA-A*02 and the risk of CML, and we discuss this in the context of recent immunological studies reporting data on BCR-ABL fusion peptide presentation and subsequent immune response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476650.RAB-nzCY73edFxBNgb6CdLjUYFzvy7ZfFZzbJZNpy-NFw130_provenance.
- NP73706.RANK7IZjWCNqkrmNXX2YFytS3MLFu-9siamjhP9Oc1iZI130_assertion description "[To our knowledge this is the first study to demonstrate the epidemiologic association between HLA-A*02 and the risk of CML, and we discuss this in the context of recent immunological studies reporting data on BCR-ABL fusion peptide presentation and subsequent immune response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73706.RANK7IZjWCNqkrmNXX2YFytS3MLFu-9siamjhP9Oc1iZI130_provenance.
- assertion description "[To our knowledge this is the first study to demonstrate the epidemiologic association between HLA-A*02 and the risk of CML, and we discuss this in the context of recent immunological studies reporting data on BCR-ABL fusion peptide presentation and subsequent immune response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To our knowledge this is the first study to demonstrate the epidemiologic association between HLA-A*02 and the risk of CML, and we discuss this in the context of recent immunological studies reporting data on BCR-ABL fusion peptide presentation and subsequent immune response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP805807.RAjLPLvUqtyaDDJIOPqm0tw3pQuvsPGEGmE5mcdotLiH8130_assertion description "[To our knowledge this is the first study to demonstrate the epidemiologic association between HLA-A*02 and the risk of CML, and we discuss this in the context of recent immunological studies reporting data on BCR-ABL fusion peptide presentation and subsequent immune response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805807.RAjLPLvUqtyaDDJIOPqm0tw3pQuvsPGEGmE5mcdotLiH8130_provenance.
- NP103959.RAP2rDRihzlQLihMhFj9SFhPoZEvz9oq_K6fs4IFc6GOI130_assertion description "[To our knowledge this is the first study to demonstrate the epidemiologic association between HLA-A*02 and the risk of CML, and we discuss this in the context of recent immunological studies reporting data on BCR-ABL fusion peptide presentation and subsequent immune response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103959.RAP2rDRihzlQLihMhFj9SFhPoZEvz9oq_K6fs4IFc6GOI130_provenance.
- NP450924.RAxdSL6yMfm6jZ-d5L4XhIL6c7bA8Wm_oqDcNcHGXUOo8130_assertion description "[To our knowledge this is the first study to demonstrate the epidemiologic association between HLA-A*02 and the risk of CML, and we discuss this in the context of recent immunological studies reporting data on BCR-ABL fusion peptide presentation and subsequent immune response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450924.RAxdSL6yMfm6jZ-d5L4XhIL6c7bA8Wm_oqDcNcHGXUOo8130_provenance.
- NP172699.RAzzY7Lw4_Y1dBZlmfQqfKfeGFYUxn256MP_khEVhVkVI130_assertion description "[To our knowledge this is the first study to demonstrate the epidemiologic association between HLA-A*02 and the risk of CML, and we discuss this in the context of recent immunological studies reporting data on BCR-ABL fusion peptide presentation and subsequent immune response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP172699.RAzzY7Lw4_Y1dBZlmfQqfKfeGFYUxn256MP_khEVhVkVI130_provenance.